There were 483 press releases posted in the last 24 hours and 438,033 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
PhaseBio Announces Positive Results From Phase 1 Clinical Trial of PB2452, a Novel Reversal Agent for Ticagrelor

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image